Navigation Links
Will Lipodissolve Continue to Remain Popular?
Date:12/12/2007

Leading Dermatologist Doing His Part to Warn Consumers

OMAHA, Neb., Dec. 12 /PRNewswire/ -- Lipodissolve, a treatment for unwanted fat, has been in the news for the past several years with significant controversy about its effectiveness and safety. Now, Fig, the parent company for up to 18 facilities around the country that offer this treatment and defender of this procedure, has closed its stores and is considering declaring bankruptcy. This is in addition to a longtime 'unsatisfactory' rating by the St. Louis Better Business Bureau, with 102 complaints over a year's period.

Despite the closure of this company, there are many companies still selling the non FDA approved substance, PC/DC, which is used for this procedure. Joel Schlessinger, M.D., Board-Certified Dermatologist and Board-Certified General Cosmetic Surgeon and immediate past-president of the American Society of Cosmetic Dermatology and Aesthetic Surgery (ASCDAS), has been involved in spotlighting the dangers of treatment. He is also involved in efforts to stop this treatment from being performed in his state, Nebraska. Just Monday, December 10th, Kansas enacted stricter restrictions on this procedure.

"It doesn't surprise me that Fig closed down -- the handwriting was on the wall when they received the unsatisfactory rating from the BBB. While I've been working on the Lipodissolve issue, many people have sustained harm from this unapproved procedure. Now, countless people have lost their money without any recourse due to the financial uncertainty of this company," says Schlessinger.

"Patient safety shouldn't be put in jeopardy for the sake of making a profit," said Joel Schlessinger M.D., founder of LovelySkin.com. "I've seen half a dozen cases of patients who received treatments and then had pain, swelling, bruising, bloating in the treatment areas, irregular dimpling and divots in the skin. Hopefully, this closure will stop some of this from happening."

Dr. Schlessinger is available for comment on Lipodissolve and its lack of safety. Interviews with Dr. Schlessinger are available and interested media may contact the company at 772-633-8337.

About Dr. Schlessinger

Joel Schlessinger M.D., board-certified dermatologist and general cosmetic surgeon, is the immediate past-president of ASCDAS and the Nebraska Dermatology Society. He continues to work with the FDA and the Nebraska State Board of Healing Arts to regulate Lipodissolve.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Joel Schlessinger, MD http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=35185


'/>"/>
SOURCE Joel Schlessinger M.D.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Lipodissolve - Is it Safe???
2. Battle Continues Over Vietnam PTSD Numbers
3. Continued Statin Use Boosts Post-Stroke Outcomes
4. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
5. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
6. Securians Minnesota Life Continues to Climb Group Life Rankings
7. USA TODAY Continues Spirit of the USA Charity Program as Part of Newspapers 25th Anniversary Celebration
8. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
9. United States continues to have highest level of health spending
10. LehmanMillet Continues Expansion with Strategic Hires
11. Pink Ribbon Bagels Continue the Fight for a Cure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
Breaking Medicine Technology: